Haitong Securities: The moderate price reduction of traditional Chinese medicine varieties continues. The domestic pharmaceutical industry is expected to set off a wave of mergers and acquisitions. Haitong Securities released a research report saying that the moderate price reduction of traditional Chinese medicine varieties continues. In 2024, the traditional Chinese medicine industry was under pressure due to the pressure of pharmacy terminal sales and inventory pressure, and it is expected to return to a good situation in the next 25 years. In addition, the continuous technological changes in the pharmaceutical industry, the development of IPO to mergers and acquisitions and the promotion of corporate governance optimization at the shareholder level are the main reasons for promoting mergers and acquisitions in the industry. In terms of fields, mergers and acquisitions are expected to occur intensively in sub-sectors such as medical devices, Chinese medicine, medical services, blood products and scientific research services.Market News: New Zealand has put forward the reason to the United States that it hopes not to introduce new tariffs during Trump's administration.Market News: New Zealand has put forward the reason to the United States that it hopes not to introduce new tariffs during Trump's administration.
"Shanghai housing subsidy is 300,000 yuan" and "down payment is 20,000 yuan to buy 1.8 million hardcover existing houses"? Rumor has come. Recently, there have been a number of housing advertisements on the short video platform. The agent who released the housing claimed that he could receive the "housing subsidy" when buying a house in Shanghai, with the amount ranging from 200,000 yuan to 300,000 yuan. An intermediary declared: "Shanghai Songjiang New Town has a total price of 760,000 yuan and a housing subsidy of 250,000 yuan." "After receiving the subsidy, you can buy a 78-square-meter house with a down payment of 50,000 yuan." There is also an intermediary who claims: "The minimum payment can be only 20,000 yuan, and you can buy a finely decorated existing house with a total price of 1.8 million yuan." The reporter consulted a number of intermediaries and learned that the so-called "purchase subsidies" appearing in short videos are not government subsidies, but gimmicks. When the house-watchers consult subsidies on the spot, different intermediaries will have different calibers. Usually, there are three routines-one is to raise the price first and then lower the price. Second, the so-called "subsidy" is actually that developers lend money to buyers to pay down payment, and buyers have to pay interest. Third, the commission returned by the intermediary to the buyers is packaged as a "subsidy". (Shanghai rumor platform)The A-share financing balance hit a new high of more than 9 years, and the big consumption sector broke out. According to china securities journal, on December 12, the A-share market opened lower and went higher. At the close, the Shanghai Composite Index rose by nearly 1%, the Shenzhen Composite Index rose by 1% and the Growth Enterprise Market Index rose by more than 1%. More than 3,500 stocks in the entire A-share market rose, with more than 150 stocks trading daily, and the big consumer sector broke out. The market turnover was 1.89 trillion yuan, which has exceeded 1 trillion yuan for 52 consecutive trading days, setting a new record for the A-share market. In terms of funds, Wind data shows that as of December 11th, the financing balance in the A-share market was 1,875.85 billion yuan, a record high of over 9 years. In the first three trading days of this week, the financing balance "increased three times in a row", with a cumulative increase of 22.579 billion yuan. Analysts believe that short-term ample liquidity and optimistic policy expectations are still the main support of the market. In the medium and long term, the A-share market is expected to continue to fluctuate upward under the dual promotion of policy expectations and economic trends.Bezos' Amazon plans to donate $1 million to Trump's inauguration ceremony.
China's agricultural science and technology strength ranks first in the world, China's agricultural science and technology papers rank first in the world, China's agricultural science and technology papers rank first in the world, and China's agricultural patent competitiveness index ranks first in the world for the first time ... On December 12, 2024, the China Agricultural and Rural Science and Technology Development Forum and the conference on global agricultural research hotspots and scientific and technological competitiveness achievements were held in Beijing. At the meeting, the results reports of think tanks such as "2024 China Agricultural Science and Technology Papers and Patent Global Competitiveness Analysis" were released, and a group of bright data conveyed the vigorous trend that China's agricultural science and technology strength continued to rank first in the world.At the end of new york on Thursday (December 12th), the main contract of CME Bitcoin futures BTC was reported at $100,000, down 1.90% from the end of new york on Wednesday. The main contract of CME ethereum futures DCR was reported at $3,888.50, up 0.52% from Wednesday.Haitong Securities: The moderate price reduction of traditional Chinese medicine varieties continues. The domestic pharmaceutical industry is expected to set off a wave of mergers and acquisitions. Haitong Securities released a research report saying that the moderate price reduction of traditional Chinese medicine varieties continues. In 2024, the traditional Chinese medicine industry was under pressure due to the pressure of pharmacy terminal sales and inventory pressure, and it is expected to return to a good situation in the next 25 years. In addition, the continuous technological changes in the pharmaceutical industry, the development of IPO to mergers and acquisitions and the promotion of corporate governance optimization at the shareholder level are the main reasons for promoting mergers and acquisitions in the industry. In terms of fields, mergers and acquisitions are expected to occur intensively in sub-sectors such as medical devices, Chinese medicine, medical services, blood products and scientific research services.
Strategy guide
Strategy guide
12-14
Strategy guide 12-14